Citations (69)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (22)
Daniel J. Oh, Judy L. Chen, Thasarat S. Vajaranant & Mark S. Dikopf. (2019) Brimonidine tartrate for the treatment of glaucoma. Expert Opinion on Pharmacotherapy 20:1, pages 115-122.
Read now
Read now
Anne J Lee & Peter McCluskey. (2008) Fixed combination of topical brimonidine 0.2% and timolol 0.5% for glaucoma and uncontrolled intraocular pressure. Clinical Ophthalmology 2:3, pages 545-555.
Read now
Read now
Miller J. Ogidigben & David E. Potter. (2002) Pharmacological evidence of a role for prejunctionalimidazoline (I1) receptors in ocular function. Current Eye Research 25:5, pages 267-270.
Read now
Read now
Hiroki Nii, Hiromi Ikeda, Koji Okada, Takeshi Yoshitomi & Douglas S. Gregory. (2001) Circadian change of adenylate cyclase activity in rabbit ciliary processes. Current Eye Research 23:4, pages 248-255.
Read now
Read now
Show-Jen Hong, Kwou-Yeung Wu & Ing-Jun Chen. (1998) Ocular hypotensive and vasodilative effects of two β-adrenergic blockers with intrinsic sympathomimetic activity. Current Eye Research 17:7, pages 700-707.
Read now
Read now
Louis B Cantor & James Burke. (1997) Brimonidine. Expert Opinion on Investigational Drugs 6:8, pages 1063-1083.
Read now
Read now
M. A. Bayorh, E. Ogbolu & R. R. Socci. (1997) Cardiovascular Effects of Oxymetazoline and UK14,304 in Conscious and Pithed Rats. Clinical and Experimental Hypertension 19:4, pages 445-460.
Read now
Read now
David S. Greenfield, Jeffrey M. Liebmann & Robert Ritch. (1997) Advances in Glaucoma Therapy: Brimonidine Tartrate. Seminars in Ophthalmology 12:3, pages 127-133.
Read now
Read now
Craig E. Crosson & Tracy Gray. (1997) Response to prejunctional adenosine receptors is dependent on stimulus frequency. Current Eye Research 16:4, pages 359-364.
Read now
Read now
A. A. Acheampong, D-S. Chien, S. Lam, S. Vekich, A. Breau, J. Usansky, D. Harcourt, S. A. Munk, H. Nguyen, M. Garst & D. Tang-Liu. (1996) Characterization of brimonidine metabolism with rat, rabbit, dog, monkey and human liver fractions and rabbit liver aldehyde oxidase. Xenobiotica 26:10, pages 1035-1055.
Read now
Read now
Ewen Macdonald, Jaana Vartiainen, Kari Jäsberg, Lauri Vuorilehto, Jarmo S. Salonen & Arto Urtti. (1993) Systemic absorption and systemic effects of ocularly administered dexmedetomidine in rabbits. Current Eye Research 12:5, pages 451-460.
Read now
Read now
DF Woodward & MF Chan. (1992) Overview: Recent Developments in Glaucoma Therapy. Current Opinion on Therapeutic Patents 2:3, pages 287-304.
Read now
Read now
Craig K. Crosson, Ashley R. Heath, Gerald W. Devries & David E. Potter. (1992) Pharmacological evidence for heterogeneity of ocular $aL2 adrenoceptors. Current Eye Research 11:10, pages 963-970.
Read now
Read now
Craig E. Crosson. (1992) Ocular hypotensive activity of the adenosine agonist (R)-phenylisopropyladenosine in rabbits. Current Eye Research 11:5, pages 453-458.
Read now
Read now
Edward L. McNellis & Larry P. Bausher. (1991) Stimulatory and inhibitory cyclic AMP responses in rabbit ciliary processes after cervical ganglionectomy. Current Eye Research 10:5, pages 399-407.
Read now
Read now
Du-Shieng Chien, James J. Homsy, Charles Gluchowski & Diane D.-S. Tang-Liu. (1990) Corneal and Conjunctival/Scleral Penetration of p-Aminoclonidine, AGN 190342, and Clonidine in Rabbit Eyes. Current Eye Research 9:11, pages 1051-1059.
Read now
Read now
Larry P. Bausher, Douglas S. Gregory & Marvin L. Sears. (1989) Alpha2-adrenergic and VIP receptors in rabbit ciliary processes interact. Current Eye Research 8:1, pages 47-54.
Read now
Read now
James Burke, Craig Crosson & David Potter. (1989) Can UK-14, 304-18 lower IOP in rabbits by a peripheral mechanism?. Current Eye Research 8:6, pages 547-552.
Read now
Read now
Pascal Kintz, Jacques Himber, Georges de Burlet & Guy Andermann. (1988) Characterization of alpha2-adrenergic receptors, negatively coupled to adenylate cyclase, in rabbit ciliary processes. Current Eye Research 7:3, pages 287-292.
Read now
Read now
James E. Jumblatt, John G.H. Liu & Ginnie T. North. (1987) Alpha-2 adrenergic modulation of norepinephrine secretion in the perfused rabbit iris-ciliary body. Current Eye Research 6:6, pages 767-777.
Read now
Read now
Larry P. Bausher, Douglas S. Gregory & Marvin L. Sears. (1987) Interaction between alpha2-and beta2-adrenergic receptors in rabbit ciliary processes. Current Eye Research 6:3, pages 497-505.
Read now
Read now
Craig E. Crosson, James A. Burke, Ming-Fai Chan & David E. Potter. (1987) Ocular Effects of a N,N-Disubstituted 5-OH Aminotetralin (N-0437): Evidence for a Dual Mechanism of Action. Current Eye Research 6:11, pages 1319-1326.
Read now
Read now
Articles from other publishers (47)
Ajay J. Khopade, Arindam HalderVivek PatelShivam UpadhyayVinod BuradeBharat PateliyaSatish PanchalSanjay MandhaneChandan AwatiMurlidhar Zope. (2023) Preclinical Evaluation of a Novel Once-a-Day Brimonidine Ophthalmic Nanosuspension. Journal of Ocular Pharmacology and Therapeutics 39:9, pages 631-642.
Crossref
Crossref
Yusuke Orii, Eriko Kunikane, Yutaka Yamada, Masakazu Morioka, Kentaro Iwasaki, Shogo Arimura, Akemi Mizuno & Masaru Inatani. (2023) Ocular Distribution of Brimonidine and Brinzolamide after Topical Instillation of a 0.1% Brimonidine Tartrate and 1% Brinzolamide Fixed-Combination Ophthalmic Suspension: An Interventional Study. Journal of Clinical Medicine 12:13, pages 4175.
Crossref
Crossref
Hidenobu Tanihara, Tetsuya Yamamoto, Makoto Aihara, Koji Kawakita, Satoshi Kojima, Mizuho Kanazawa, Toshiaki Nojima & Hideki Suganami. (2023) Ripasudil–Brimonidine Fixed-Dose Combination vs Ripasudil or Brimonidine: Two Phase 3 Randomized Clinical Trials. American Journal of Ophthalmology 248, pages 35-44.
Crossref
Crossref
Sara M. Thomasy. 2022. Wild and Exotic Animal Ophthalmology. Wild and Exotic Animal Ophthalmology
483
543
.
Veysel Cankurtaran & Kemal Tekin. (2021) Effects of a Single Dose of Topical Brimonidine 0.15% on Anterior Segment Morphology, Pupil Characteristics, and Choroidal Thickness in Healthy Subjects. Eye & Contact Lens: Science & Clinical Practice 47:6, pages 323-329.
Crossref
Crossref
Teppei Kanda, Chisato Toda, Haruka Morimoto, Yuki Shimizu, Takamasa Itoi, Kayo Furumoto, Yasuhiko Okamura & Eri Iwata. (2019) Antiemetic effect of oral maropitant treatment before the administration of brimonidine ophthalmic solution in healthy cats. Journal of Feline Medicine and Surgery 22:6, pages 557-563.
Crossref
Crossref
H.M. Himmel & T.M. Eriksson Faelker. (2019) Pupillary function test in rat: Establishment of imaging setup and pharmacological validation within modified Irwin test. Journal of Pharmacological and Toxicological Methods 99, pages 106588.
Crossref
Crossref
S. M. Thomasy & M. Lassaline. (2015) Equine glaucoma: Where are we now?. Equine Veterinary Education 27:8, pages 420-429.
Crossref
Crossref
Adam C Reynolds. 2015. Glaucoma. Glaucoma
566
576
.
Emi Kaneko, Tomoyuki Wada, Yoko Minagawa & Yutaka Inoue. (2012) Pharmacological profile and clinical efficacy of brimonidine tartrate (AIPHAGAN^|^reg; ophthalmic solution 0.1%). Folia Pharmacologica Japonica 140:4, pages 177-182.
Crossref
Crossref
Jouko Savolainen, Riku Niemi, Antti Mäntylä, Juhani Huuskonen & Tomi Järvinen. (2005) Fadolmidine-induced ocular hypotension in normotensive rabbits. Journal of Pharmacy and Pharmacology 57:2, pages 191-195.
Crossref
Crossref
Jouko Savolainen, Jarkko Rautio, Roberta Razzetti & Tomi Järvinen. (2003) A novel D2-dopaminergic and α2-adrenoceptor receptor agonist induces substantial and prolonged IOP decrease in normotensive rabbits. Journal of Pharmacy and Pharmacology 55:6, pages 789-794.
Crossref
Crossref
David F. Woodward, Achim H.-P. Krauss & Siv F. E. Nilsson. (2010) Bimatoprost Effects on Aqueous Humor Dynamics in Monkeys. Journal of Ophthalmology 2010, pages 1-5.
Crossref
Crossref
Assumpta Peral, Juana Gallar & Jesús Pintor. (2009) Adenine nucleotide effect on intraocular pressure: Involvement of the parasympathetic nervous system. Experimental Eye Research 89:1, pages 63-70.
Crossref
Crossref
ELIZABETH WOLDEMUSSIE, MERCY WIJONO & DAVID POW. (2007) Localization of alpha 2 receptors in ocular tissues. Visual Neuroscience 24:5, pages 745-756.
Crossref
Crossref
Hans Gerhard Vogel. 2008. Drug Discovery and Evaluation. Drug Discovery and Evaluation
1917
1939
.
Riku Niemi, Juhani Huuskonen, Krista Laine & Tomi Järvinen. (2005) Synthesis, hydrolysis, and intraocular pressure lowering effects of fadolmidine prodrugs. International Journal of Pharmaceutics 295:1-2, pages 121-127.
Crossref
Crossref
Michel Bernhard, Kenneth Takeda, Caroline Keller, Mirko Haslebacher, George N. Lambrou & Anne-Ulrike Trendelenburg. (2004) 3H-noradrenaline release from mouse iris?ciliary body: role of presynaptic muscarinic heteroreceptors. Naunyn-Schmiedeberg's Archives of Pharmacology 370:4, pages 305-313.
Crossref
Crossref
Herbert A. Reitsamer, Jeffrey W. Kiel, Joseph M. Harrison, Nancy L. Ransom & Stuart J. McKinnon. (2004) Tonopen measurement of intraocular pressure in mice. Experimental Eye Research 78:4, pages 799-804.
Crossref
Crossref
Mitsutaka SODA, Masato YOSHIDA, Hidetoshi ONDA, SHI-YU Guo, Takako NAKANISHI-UEDA, Toshihiko UEDA, Noriko FUJISHIRO, Tadashi HISAMITSU, Makoto INATOMI, Hajime YASUHARA, Katsuji OGUCHI & Ryohei KOIDE. (2003) The Effect of Brimonidine on Intraocular Pressure via the Central Nervous System in the Conscious Pigmented Rabbit. The Showa University Journal of Medical Sciences 15:4, pages 313-322.
Crossref
Crossref
Jesús Pintor, Assumpta Peral, Teresa Peláez, Silvia Martı́n & Charles H. V. Hoyle. (2003) Presence of Diadenosine Polyphosphates in the Aqueous Humor: Their Effect on Intraocular Pressure. Journal of Pharmacology and Experimental Therapeutics 304:1, pages 342-348.
Crossref
Crossref
Kirk N. Gelatt & Edward O. MacKay. (2002) Effect of single and multiple doses of 0.2% brimonidine tartrate in the glaucomatous Beagle. Veterinary Ophthalmology 5:4, pages 253-262.
Crossref
Crossref
H. Gerhard Vogel, Wolfgang H. Vogel, Bernward A. Schölkens, Jürgen Sandow, Günter Müller & Wolfgang F. Vogel. 2002. Drug Discovery and Evaluation. Drug Discovery and Evaluation
1295
1308
.
Miller J. Ogidigben, Teh-Ching Chu & David E. Potter. (2001) Naphazoline-induced Suppression of Aqueous Humor Pressure and Flow: Involvement of Central and Peripheral α2/I1Receptors. Experimental Eye Research 72:3, pages 331-339.
Crossref
Crossref
Anuja Bhandari, George A Cioffi, E.Michael Van Buskirk, Selim Orgül & Lin Wang. (1999) Effect of brimonidine on optic nerve blood flow in rabbits. American Journal of Ophthalmology 128:5, pages 601-605.
Crossref
Crossref
GIORGIO MARCHINI, SILVIA BABIGHIAN, ROBERTO TOSI & LUCIANO BONOMI. (1999) Effects of 0.2% Brimonidine on Ocular Anterior Structures. Journal of Ocular Pharmacology and Therapeutics 15:4, pages 337-344.
Crossref
Crossref
Carol B Toris, Carl B Camras & Michael E Yablonski. (1999) Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients. American Journal of Ophthalmology 128:1, pages 8-14.
Crossref
Crossref
B. Brogliatti, C. Bogetto, B. Prandi & B. Boles Carenini. (2009) Pupillographic, tonographic and refractive parameter changes after topical instillation of Brimonidine tartrate 0.2% in healthy subjects. Acta Ophthalmologica Scandinavica 76:S227, pages 34-35.
Crossref
Crossref
TEH-CHING CHU, ROBIN R. SOCCI, MILLER J. OGIDIGBEN & DAVID E. POTTER. (1997) Potential Mechanisms of Moxonidine-Induced Ocular Hypotension: Role of Norepinephrine. Journal of Ocular Pharmacology and Therapeutics 13:6, pages 489-496.
Crossref
Crossref
Robert J. Derick, Alan L. Robin, T.R. Walters, Howard S. Barnebey, Neil Choplin, Joel Schuman, Elaine P. Kelley, Kuankuan Chen & Jack F. Stoecker. (1997) Brimonidine Tartrate. Ophthalmology 104:1, pages 131-136.
Crossref
Crossref
James Burke & Michal Schwartz. (1996) Preclinical evaluation of brimonidine. Survey of Ophthalmology 41, pages S9-S18.
Crossref
Crossref
O.V. AngelovA.G. WieseD.D. Tang-LiuA.A. AcheampongI.M. IsmailB.S. Brar. (2018) Preclinical Safety Profile of Brimonidine. European Journal of Ophthalmology 6:1, pages 21-25.
Crossref
Crossref
EVAN F. WILLIAMS, TEH-CHING CHU, ROBIN R. SOCCI, LESTER G. BROWN, CASSANDRA E. WALKER & ERROL L. MANOR. (1996) Comparison of Nucleoside Transport Binding Sites in Rabbit Iris-Ciliary Body and Cultured Rabbit Nonpigmented Ciliary Epithelial Cells. Journal of Ocular Pharmacology and Therapeutics 12:4, pages 461-469.
Crossref
Crossref
Yoon T. Jeon, Chi Luo, Carlos Forray, Pierre J.-J. Vaysse, Theresa A. Branchek & Charles Gluchowski. (1995) Pharmacological evaluation of UK-14,304 analogs at cloned human α adrenergic receptors. Bioorganic & Medicinal Chemistry Letters 5:19, pages 2255-2258.
Crossref
Crossref
Anonymous. (1995) Effect of Brimonidine 0.5% on Intraocular Pressure Spikes Following 360° Argon Laser Trabeculoplasty. Ophthalmic Surgery, Lasers and Imaging Retina 26:5, pages 404-409.
Crossref
Crossref
S.A. Munk, D. Harcourt, P. Arasasingham, C. Gluchowski, H. Wong, J. Burke, A. Kharlamb, C. Manlapaz, E. Padillo, L. Williams, L. Wheeler & M. Garst. (1995) Analogs of UK 14,304: Structural features responsible for α2 adrenoceptor activity. Bioorganic & Medicinal Chemistry Letters 5:15, pages 1745-1750.
Crossref
Crossref
W. RICHARD CAMPBELL & DAVID E. POTTER. (1995) Centrally Mediated Ocular Hypotension: Potential Role of Imidazoline Receptors. Annals of the New York Academy of Sciences 763:1 The Imidazoli, pages 463-485.
Crossref
Crossref
JAMES BURKE, ALEX KHARLAMB, TANVEER SHAN, EILEEN RUNDE, EDWIN PADILLO, CYNTHIA MANLAPAZ & LARRY WHEELER. (1995) Adrenergic and Imidazoline Receptor-Mediated Responses to UK-14,304-18 (Brimonidine) in Rabbits and Monkeys.. Annals of the New York Academy of Sciences 763:1 The Imidazoli, pages 78-95.
Crossref
Crossref
W.Richard Campbell & David E. Potter. (1994) The central effects of moxonidine on intraocular pressure and its antagonism by L-659, 066 and L-657, 743 in the rabbit. Progress in Neuro-Psychopharmacology and Biological Psychiatry 18:6, pages 1051-1061.
Crossref
Crossref
S.A. Munk, C. Gluchowski, L. Dolby, H. Wong, J. Burke, A. Kharlamb, C. Manlapaz, E. Padillo, D. Rodgers, B. Ohta, L. Wheeler & M. Garst. (1994) Analogs of UK 14,304 as α2-adrenoceptor agonists. Twist and agent polarity as design elements.. Bioorganic & Medicinal Chemistry Letters 4:3, pages 459-462.
Crossref
Crossref
W. RICHARD CAMPBELL & DAVID E. POTTER. (1994)
Potential Role of Imidazoline (I
1
) Receptors in Modulating Aqueous Humor Dynamics
. Journal of Ocular Pharmacology and Therapeutics 10:1, pages 393-402.
Crossref
Crossref
MICHAEL C. KOSS & TSEGGAI GHEREZGHIHER. (1994)
Ocular Effects of α
2
-Adrenoceptor Activation in Anesthetized Cats
. Journal of Ocular Pharmacology and Therapeutics 10:1, pages 149-156.
Crossref
Crossref
Ewen MacDonald, Jaana Vartiainen, Kari Jäsberg & Arto Urtti. (2008)
Comparison of the cardiovascular effects of the α
2
‐adrenoceptor agonist, dexmedetomidine, in rats and rabbits
. Drug Development Research 28:4, pages 473-477.
Crossref
Crossref
TEH-CHING CHU, MILLER OGIDIGBEN, JOAN C. HAN & DAVID E. POTTER. (1993) Allicin-Induced Hypotension in Rabbit Eyes. Journal of Ocular Pharmacology and Therapeutics 9:3, pages 201-209.
Crossref
Crossref
DAVID E. POTTER, CRAIG E. CROSSON, ASHLEY R. HEATH & MILLER J. OGIDIGBEN. (1990)
Alpha
2
and DA
2
Agonists as Antiglaucoma Agents: Comparative Pharmacology and Clinical Potential
. Journal of Ocular Pharmacology and Therapeutics 6:3, pages 251-257.
Crossref
Crossref
YING JIN, E.E. ELKO, TUNG TRAN & THOMAS YORIO. (1989)
Inhibition of Adenylate Cyclase in Bovine Ciliary Process and Rabbit Iris Ciliary Body to Alpha
2
-Adrenergic Agonists
. Journal of Ocular Pharmacology and Therapeutics 5:3, pages 189-197.
Crossref
Crossref
Michael F. Sugrue. (1989) The pharmacology of antiglaucoma drugs. Pharmacology & Therapeutics 43:1, pages 91-138.
Crossref
Crossref